Brown Ashleigh, Hofman Paul, Li Bobby, Heron Campbell, Heather Natasha
Starship Child Health, Te Whatu Ora Te Toka Tumai Auckland, Auckland 1023, New Zealand.
Liggins Institute, University of Auckland, Auckland 1023, New Zealand.
Int J Neonatal Screen. 2023 Mar 23;9(2):16. doi: 10.3390/ijns9020016.
Newborn screening for congenital hypothyroidism (CH) has dramatically improved the neurocognitive outcomes for newborns with a confirmed positive screening test result. However, screening yields a small number of false positive and false negative results. This report describes the first known case of familial dysalbuminaemic hyperthyroxinaemia presenting with a positive newborn thyroid stimulating hormone screen. This condition is characterized by artefactually elevated free tetraiodothyronine (T4) and triiodothyronine (T3) levels due to increased albumin binding and subsequent dissociation during laboratory assays but normal true free thyroid hormone and thyroid stimulating hormone (TSH) levels in a clinically euthyroid subject. This highlights the need to take care when attributing clinical significance to discordant results.
先天性甲状腺功能减退症(CH)的新生儿筛查显著改善了筛查结果确诊为阳性的新生儿的神经认知结局。然而,筛查会产生少量假阳性和假阴性结果。本报告描述了首例家族性白蛋白异常血症性甲状腺素过多症表现为新生儿促甲状腺激素筛查阳性的病例。这种情况的特征是,由于白蛋白结合增加以及实验室检测过程中随后的解离,导致游离甲状腺素(T4)和三碘甲状腺原氨酸(T3)水平出现人为升高,但临床甲状腺功能正常的受试者的真正游离甲状腺激素和促甲状腺激素(TSH)水平正常。这凸显了在赋予不一致结果临床意义时需谨慎的必要性。